Precigen, Inc. (PGEN)
8.54
+0.33
(+4.02%)
USD |
NASDAQ |
Oct 02, 16:00
8.52
-0.02
(-0.23%)
After-Hours: 20:00
Precigen Price to Book Value : 70.16 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 70.16 |
| October 01, 2026 | 67.45 |
| September 30, 2026 | 70.33 |
| September 29, 2026 | 66.14 |
| September 28, 2026 | 64.16 |
| September 25, 2026 | 63.67 |
| September 24, 2026 | 63.26 |
| September 23, 2026 | 61.12 |
| September 22, 2026 | 64.82 |
| September 21, 2026 | 63.26 |
| September 18, 2026 | 63.92 |
| September 17, 2026 | 64.66 |
| September 16, 2026 | 61.08 |
| September 15, 2026 | 57.51 |
| September 14, 2026 | 56.28 |
| September 11, 2026 | 56.28 |
| September 10, 2026 | 54.88 |
| September 09, 2026 | 55.87 |
| September 08, 2026 | 56.44 |
| September 04, 2026 | 58.33 |
| September 03, 2026 | 58.66 |
| September 02, 2026 | 57.59 |
| September 01, 2026 | 56.36 |
| August 31, 2026 | 56.93 |
| August 28, 2026 | 57.10 |
| Date | Value |
|---|---|
| August 27, 2026 | 59.07 |
| August 26, 2026 | 60.96 |
| August 25, 2026 | 59.81 |
| August 24, 2026 | 58.91 |
| August 21, 2026 | 59.15 |
| August 20, 2026 | 61.12 |
| August 19, 2026 | 58.82 |
| August 18, 2026 | 55.46 |
| August 17, 2026 | 53.81 |
| August 14, 2026 | 50.12 |
| August 13, 2026 | 53.32 |
| August 12, 2026 | 56.28 |
| August 11, 2026 | 56.36 |
| August 10, 2026 | 57.51 |
| August 07, 2026 | 59.40 |
| August 06, 2026 | 56.77 |
| August 05, 2026 | 56.61 |
| August 04, 2026 | 53.65 |
| August 03, 2026 | 54.30 |
| July 31, 2026 | 51.51 |
| July 30, 2026 | 48.80 |
| July 29, 2026 | 44.77 |
| July 28, 2026 | 45.43 |
| July 27, 2026 | 44.53 |
| July 24, 2026 | 44.36 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Repligen Corp. | 4.854 |
| AC Immune SA | 5.694 |
| Amgen, Inc. | 18.64 |
| Geron Corp. | 3.527 |
| Neurocrine Biosciences, Inc. | 3.938 |
Price to Book Value Related Metrics
| PS Ratio | 35.59 |
| PEG Ratio | -0.0496 |
| Price | 8.54 |
| Earnings Yield | -12.87% |
| Market Cap | 3.057B |
| PEGY Ratio | -0.0496 |